[Pharmwaste] Comment on ONDCP's 2013 National Drug Control Strategy by 7/20

Mon Jul 9 20:01:54 EDT 2012

Finally, and having been fearful that drug disposal would not be part of
it...relief.

On Mon, Jul 9, 2012 at 4:29 PM, Lucy, Burke <Burke.Lucy at calrecycle.ca.gov>wrote:

>  Speaking of minimizing drug prescriptions…
>
>
>
> *FDA introduces new safety measures for extended-release and long-acting
> opioid medications*
>
>
> http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm310870.htm?source=govdelivery
>
> “The U.S. Food and Drug Administration today approved a risk evaluation
> and mitigation strategy…part of a federal initiative to address the
> prescription drug abuse, misuse, and overdose epidemic.”
>
>
>
> Burke
>
>
>
>
>
> Mr. Burke Lucy
>
> Integrated Waste Management Specialist
>
> Department of Resources Recycling and Recovery (CalRecycle)
>
> 1001 I Street, PO Box 4025
>
> Sacramento, CA 95812
>
> Burke.Lucy at CalRecycle.ca.gov
>
> 916.341.6592
>
>
>
> *From:* pharmwaste-bounces at lists.dep.state.fl.us [mailto:
> pharmwaste-bounces at lists.dep.state.fl.us] *On Behalf Of *Zimmer,
> Catherine (PSC)
> *Sent:* Monday, July 09, 2012 8:34 AM
> *To:* Galvin, Dave; pharmwaste at lists.dep.state.fl.us
> *Subject:* RE: [Pharmwaste] Comment on ONDCP's 2013 National Drug Control
> Strategy by 7/20
>
>
>
> Hi Dave and all,
>
> Dave, thank you for the prompt and summary re: ONDCP’s comment period.  I
> would add that the best way to minimize drug waste is to minimize drug
> prescriptions.  So, including language to support CMS’ recent ruling
> regarding pro-rated copays for trial prescriptions and advocacy for
> non-drug interventions is a key tool to minimizing waste and the risk of
> diversion.
>
>
>
>
>
> Very truly yours,
>
>
>
> Catherine Zimmer, MS, BSMT
>
> Industry Leader, Environmental and Regulatory
>
> PSC Healthcare Services
>
> Office:  651.645.7509
>
> Mobile: 713.829.6365
>
> www.pscnow.com
>
> Catherine.zimmer at pscnow.com
>
>
>
> *Live green now!*
>
> *Reduce, reuse, repair, recycle.*
>
>
>
>
>
>
>
> *From:* pharmwaste-bounces at lists.dep.state.fl.us
> [mailto:pharmwaste-bounces at lists.dep.state.fl.us] *On Behalf Of *Galvin,
> Dave
> *Sent:* Monday, July 09, 2012 10:21 AM
> *To:* pharmwaste at lists.dep.state.fl.us
> *Subject:* [Pharmwaste] Comment on ONDCP's 2013 National Drug Control
> Strategy by 7/20
>
>
>
> A reminder that the White House Office of National Drug Control Policy is
> soliciting input for its 2013 update to the National Drug Control
> Strategy.  Comments are due by July 20, 2012.  Comments can be entered
> on-line at  http://www.whitehouse.gov/ondcp/2013strategycomments or sent
> via email to 2013Strategy at ondcp.eop.gov .
>
>
>
> The *2012 National Drug Control Strategy* (available here:
> http://www.whitehouse.gov/sites/default/files/ondcp/2012_ndcs.pdf )
> references the separate *Prescription Drug Abuse Prevention Plan* issued
> in April 2011 (available here:
> http://www.whitehouse.gov/sites/default/files/ondcp/issues-content/prescription-drugs/rx_abuse_plan.pdf).  This latter plan includes “proper medication disposal” as one of its
> four main elements for reducing prescription drug abuse.  In addition to
> supporting take-back activities and events, the plan recommends that the
> federal government “…engage PhRMA and others in the private sector to
> support community-based medication disposal programs.”
>
>
>
> I interpret such “support” to include producer responsibility for funding
> take-back programs following a product stewardship model.  Neither the
> Secure and Responsible Drug Disposal Act of 2010 nor the pending DEA
> regulations to implement it contains any funding for local take-back
> initiatives.   We need the support of the drug manufacturers in order to
> create a robust take-back network that will help to reduce prescription
> drug abuse and protect the environment.  That’s Galvin’s editorial comment.
>
>
>
> The 2012 National Drug Control Strategy references the prescription drug
> abuse prevention plan in its final “policy focus” section, pages 47-50.
> It’s whole description of proper disposal is all of two short paragraphs on
> page 49.
>
>
>
> I am going to submit a comment in order to reinforce this reference and
> the need for a robust (safe, secure, convenient, funded) system for the
> take-back and proper disposal of unused medicines.  I encourage you to
> consider adding your own voice during this brief comment period, so that
> the ONDCP hears loud-and-clear that safe, adequately-funded medicine
> take-back is an important component of the country’s drug control policy.
> It’s time.  We’ve been talking about this for nearly ten years.
>
>
>
> n  Dave Galvin
>
>
>
> *_________________________________________________________*
>
> *Dave Galvin* o King County Department of Natural Resources and Parks o 130
> Nickerson Street, Seattle, WA 98109-1658 o (w) 206-263-3085 o (fax)
> 206-263-3070 o dave.galvin at kingcounty.gov o Local Hazardous Waste
> Management Program in King County o www.lhwmp.org
>
>
>
> ---
> Note: As a courtesy to other listserv subscribers, please post messages to
> the listserv in plain text format to avoid the garbling of messages
> received by digest recipients.
> ---
> TO SUBSCRIBE, go to:
> http://lists.dep.state.fl.us/cgi-bin/mailman/listinfo/pharmwaste
> TO UNSUBSCRIBE, DO NOT REPLY TO THE LISTSERV. Please send an e-mail to
> pharmwaste-unsubscribe at lists.dep.state.fl.us -- the subject line and body
> of the e-mail should be blank.
> If you believe you may be subscribed with a different email address,
> please visit the subscriber listing at
> http://lists.dep.state.fl.us/cgi-bin/mailman/roster/pharmwaste
> FOR PROBLEMS:  Contact List Administrator Laurie.Tenace at dep.state.fl.us
> SEND MAIL to the list server at:  pharmwaste at lists.dep.state.fl.us
>
>

-- 
Stevan Gressitt, M.D., D.F.A.P.A.
Faculty Associate, University of Maine Center on Aging
Academic Member, Athens Institute for Education and Research
Athens, Greece
Founding Director, International Institute for Pharmaceutical Safety
University of New England, College of Pharmacy
Department of Pharmaceutical Sciences
Associate Professor of Clinical Psychiatry
University of New England, College of Osteopathic Medicine
314 Clark Road
Unity, Maine, 04988
gressitt at gmail.com
Cell: 207-441-0291
www.benzos.une.edu
www.safemeddisposal.com
-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20120709/5ffa2e28/attachment-0001.htm